Dren Bio - Crunchbase Company Profile & Funding

Q: Who invested in Dren Bio?

Dren Bio has 13 investors including Novartis And HBM Partners.

Q: When was the last funding round for Dren Bio?

Dren Bio closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has Dren Bio raised to date?

Dren Bio has raised obfuscated.

Overview

Dren Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Dren Bio

CB Rank

22123

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Founded

obfuscation

Private

Corporate Round

Foster City, California, United States

11-50

www.drenbio.com

Biotechnology

Health Care

Life Science

Funding Rounds

Corporate Round

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Amit Mehta: COO
Nenad Tomasevic: CEO and Founder
Past Role: Allakos, Founder & Vice President of Research

Details

Sub-Organization of

Dren Bio

Legal Name

Dren Bio, Inc.

Operating Status

Active

Company Type

For Profit

Founders

John Wesley, Nenad Tomasevic

About the Company

Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.

Contact Email

info@drenbio.com

Predictions & Insights

Growth Insight

See this Growth Insight

Dren Bio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

DR-01

An antibody therapeutic designed to selectively deplete terminally differentiated cytotoxic cells implicated in certain cancers and autoimmune diseases.

Targeted Myeloid Engager and Phagocytosis Platform

A bispecific antibody technology that engages myeloid cells to induce targeted phagocytosis and depletion of pathogenic cells and disease-causing agents.

Research & Development

Dren Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round
obfuscated obfuscation	Corporate Round - Dren Bio	1	obfuscated obfuscation	Novartis	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Novartis	Yes	Corporate Round - Dren Bio	—
Novartis	Yes	Corporate Round - Dren Bio	—
Novartis	Yes	Corporate Round - Dren Bio	—
Novartis	Yes	Corporate Round - Dren Bio	—
Novartis	Yes	Corporate Round - Dren Bio	—